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Background and objectives: The prognostic role of B-type natriuretic peptide (BNP) in septic patients is
controversial. The study aimed to investigate the prognostic value of BNP in critically ill septic patients. Furthermore,
because BNP is primarily released from ventricles in response to myocardial stretch, the second aim of the study
was to test whether the change in BNP was correlated to the amount of fluid balance.
Methods: This was a prospective observational study conducted in a tertiary 18-bed ICU. Patients fulfilled criteria of
sepsis were enrolled. Exclusion criteria included renal dysfunction on ICU entry, age < 18 or >80 years old. BNP was
measured on entry (BNP0) and day 3 (BNP1) and daily fluid balance over the three days were recorded. Diagnostic
performances of BNP0 and ΔBNP (BNP1-BNP0) were analyzed. The correlation between fluid balance and ΔBNP
were tested using Spearman’s correlation test.
Results: A total of 67 subjects were eligible for the study during study period. BNP0 was significantly higher in
non-survivors than in survivors (738 vs 550 pg/ml, p < 0.01). The area under curves (AUCs) of BNP0 in predicting
mortality, duration of mechanical ventilation (MV) > 7 d, length of stay in ICU (LOSICU) > 7 d and hospital
(LOShospital) > 12 d were 0.71, 0.79, 0.66 and 0.71, respectively. The AUCs of ΔBNP in predicting duration of MV > 7 d,
LOSICU > 7 d and LOShospital > 12 d were 0.80, 0.84 and 0.85, respectively. The amount of fluid balance was
correlated to ΔBNP (Spearman’s rho = 0.63, p < 0.01), and the correlation remained statistically significant in
multivariate model.
Conclusions: BNP measured on ICU entry is associated with mortality, duration of MV, LOSICU and LOShospital. ΔBNP
is able to predict the LOSICU and LOShospital with satisfactory sensitivity and specificity. ΔBNP is closely correlated to
the amount of fluid balance during resuscitation period. However, this could only be considered as a
hypothesis-generating pilot study due to its small sample size and the observational nature.
Keywords: B-type natriuretic peptide, Fluid loading, Sepsis, OutcomeIntroduction
Sepsis is a leading cause of mortality and morbidity in
intensive care unit (ICU). It is estimated that 3 in 1000
people will be affected by sepsis, and 51% of them
requires ICU admission [1]. The presence of cardiovas-
cular dysfunction in septic patients is found to be asso-
ciated with worse clinical outcome [2,3]. Underlying
mechanisms of cardiovascular depression include over-* Correspondence: zh_zhang1984@hotmail.com
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reproduction in any medium, provided the orproduction of reactive oxygen species, lipid peroxidation,
and impaired calcium homeostasis [4,5]. In this regard,
biomarkers of cardiac dysfunction may help to identify
patients at risk of death early. For instance, the conven-
tional biomarkers of Troponin T and I have been exten-
sively investigated in septic patients and those with
elevated troponin levels were 2–3 times more likely to
die [6,7].
B-type natriuretic peptide (BNP) is a 32 amino acid
that is synthesized and secreted by myocytes and fibro-
blasts in the atria and ventricle in response to wall stress
[8,9]. It has been widely accepted that BNP is a usefulLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nosis, risk stratification, and BNP-guided treatment
[10-12]. More recently, many investigators have identi-
fied its value in critical care settings. Some found that
BNP might be helpful in guiding fluid therapy [13], and
others found that BNP was associated with clinical out-
comes [14,15]. However, these results are conflicting due
to the heterogeneity of study subjects. We hypothesized
that 1) baseline BNP concentration was associated with
clinical outcome in septic patients in ICU; and 2) change
in BNP after fluid therapy was associated with clinical




The study was conducted in a tertiary 18-bed ICU from
September 2010 to March 2012. This was a mixed ICU
enrolling both surgical and medical patients. During the
study period, patients entered ICU were prospectively
assessed for potential eligibility. Patients were eligible if
they fulfilled the following criteria: 1) sepsis defined as
systemic inflammatory response syndrome (SIRS) plus
infection. SIRS was defined by the presence of more
than one of the following criteria: body temperature,
>38°C or <36°C; heart rate, >90 min-1; hyperventilation
evidenced by a respiratory rate of >20 min-1 or a PaCO2
of <32 mm Hg (4.3 kPa); and a white blood cell count of
>12,000 cells μL-1 or <4,000 μL-1. Infection was conside-
red by the presence of clinical signs and inflammatory
markers, and the presence of polymorphonuclear cells in
normally sterile tissue or fluid and/or culture or gram
stain showing a pathogenic microorganism and/or ra-
diological evidence of an infective focus [16]. 2) patients
aged between 18 and 80 years old. 3) Patients who re-
quired hemodynamic monitoring or quantitative assess-
ment of pulmonary edema with PiCCO system. Criteria
for PiCCO monitoring included hemodynamic instabil-
ity, acute respiratory distress syndrome or both. Exclu-
sion criteria were: 1) patients with acute renal injury at a
degree of AKIN-2 or above [17]; 2) patients who were
moribund or signed Do-not-resuscitation order (DNR);
3) patients with preexisting renal dysfunction. The study
was approved by the ethic committee of Jinhua munici-
pal central hospital. Informed consent was obtained
from patient or next-of-kin.
Data collection
On enrollment, baseline characteristics of patients were
recorded, including age, sex, severity of illness as repre-
sented by Acute Physiology and Chronic Health Evalu-
ation (APACHE II), admission diagnosis, sources of
infection, hemodynamic variables (obtained by thermo-
dilution technique). During follow up, the volumes offluid balance in the first three days were recorded. The
total net fluid balance referred to net fluid balance over
the three days. Fluid balance was defined as total fluid
intake including tube feeding, intravenous infusion and
eating, minus total fluid output including urine output,
drainage of fluid, fluid removal with renal replacement
therapy and perspiration. B-type natriuretic peptide (BNP)
was measured on admission (BNP0), and on the third day
(BNP1). ΔBNP was calculated as BNP1 minus BNP0. BNP
was measured using Triage BNP detector (Triage BNP,
Biosite Company, San Diego, Calif ).
The primary end point was in hospital mortality. Sec-
ondary end points included ICU length of stay (LOSICU),
LOS in hospital (LOShospital) and duration of mechanical
ventilation (MV). For patients who had been transferred
to general ward and then were re-admitted to ICU with-
in three days, days spent in general ward were consid-
ered in ICU, and LOSICU included the first and second
LOSICU. Mechanical ventilation included invasive mech-
anical ventilation and non-invasive mechanical ventila-
tion with positive end expiratory pressure >5 cmH2O. In
our institution, we considered tracheostomy for patients
who could not wean from mechanical ventilation after
day 7, thus, we used 7 days as a threshold to convert
the continuous variable of duration of MV into a binary
variable.Statistical analysis
Data were tested for normality, and expressed as mean ±
SD (standard deviation) or median and interquartile
range as appropriate. If data were normally distributed,
the comparisons were performed using student t test,
otherwise, Wilcoxon rank-sum (Mann–Whitney) test
was used. Multivariate analysis (backward stepwise logis-
tic regression) was performed to screen independent var-
iables associated with mortality. Variables entered into
the model were defined a priori, including age, APACHE
II score, BNP0, cardiac index, and extravascular lung
water; also, variables with a p < 0.1 in univariate analysis
were entered into the model. The goodness-of-fit was
tested using Homser-Lemeshow method. Diagnostic
performance of BNP0 and ΔBNP in predicting clinical
outcomes (hospital mortality, LOSICU and LOShospital, du-
ration of mechanical ventilation) were evaluated using
receiver operating characteristic (ROC) curves. Diagnostic
statistics including sensitivity, specificity, positive likeli-
hood ratio (LR+), and negative likelihood ratio (LR-) were
reported. The correlation between total fluid balance and
ΔBNP was analyzed by using spearman’s rank correlation
test. P < 0.05 with two tailed test was considered to be sta-
tistically significant. All statistical analyses were performed
using the software Stata 11.0 (College Station, Texas
77845 USA).
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Patient enrollment and baseline characteristics
During the study period, a total of 544 patients were ad-
mitted to our ICU. 471 of them were excluded on entry
due to various reasons (Figure 1), remaining 73 patients
who fulfilled our inclusion criteria. During follow up,
six patients were lost because three were transferred to
other hospitals and the other three signed do-not-
resuscitation order in the course of treatment. Finally,
67 patients were used in the analysis.
Baseline characteristics of the patients are shown in
Table 1, and variables were compared between survivors
and non-survivors. Survivors and non-survivors were
comparable in variables including age, sex, sources of
infection, proportion of patients with MV, and hem-
odynamic variables. Survivors had significantly lower
APACHEII score than non-survivors (19 vs 31, p < 0.01).
More patients in non-survivors required at least one
vasopressor (66.7% vs 32.5%, p < 0.01). Fluid overload
during the first two days consistently showed negative
impact on survival. In total, survivors were given less
fluid than non-survivors during the first three days
(2051 vs 3086 ml, p = 0.03). Survivors had lower BNP
levels both on entry and on day 3 than non-survivors
(550 vs 738 pg/ml, p < 0.01; 594 vs 834 pg/ml, p < 0.01;
respectively).Figure 1 Flow chart of patients selection.BNP and clinical outcomes
In multivariate analysis (Table 2), BNP0 was found to be
independently associated with in hospital survival. With
each 100 pg/ml increase in BNP0, the mortality rate was
doubled (OR: 2.14, 95% CI: 1.07-4.24). APACHEII score
was also an independent predictor of in-hospital mortal-
ity. Variables such as vasopressor use, sex, day 1 fluid
balance were excluded from the regression model by
backward stepwise method. Other factors such as age
and extravascular lung water were not found to be inde-
pendently associated mortality. P value for the Homser-
Lemeshow χ2 was 0.75, suggesting a well fitted model.
Diagnostic performances of BNP0 and ΔBNP in pre-
dicting clinical outcomes are shown in Table 3. BNP0
was of diagnostic value in predicting clinical outcomes,
though the performance was only moderate. BNP0 was
able to predict mortality with an area under receiver op-
erating characteristic curve (AU-ROC) of 0.71. At the
cutoff of 816 pg/ml, the sensitivity and specificity were
48.2% and 87.5%, respectively. The AU-ROC of BNP0 in
predicting duration of MV > 7 days was 0.79, and at the
cutoff of 929 pg/ml, the sensitivity and specificity were
57.1% and 88.2%, respectively. The AU-ROC of BNP0 in
predicting LOSICU >7 days was 0.66, and at the cutoff of
828 pg/ml, the sensitivity and specificity were 40% and
89.2%, respectively. The AU-ROC of BNP0 in predicting
Table 1 Characteristics of included patients
Variables Total (n = 67) Alive (n = 40) Dead (n = 27) P value
Age (years) 59 ± 16 56 ± 15 64 ± 18 0.07
Sex (male, %) 43 (64.2) 25(62.5) 18 (66.7) 0.73
APACHEII 23 (19,31) 19 (16,23) 31 (25,38) <0.01
Sources of infection (No. %) 0.47
Lung 27 (40.3) 14 (35) 13 (48.2)
Abdomen 10 (14.9) 5 (12.5) 5 (18.5)
Urinary tract 15 (22.4) 11 (27.5) 4 (14.8)
Blood stream 15 (22.4) 10 (25) 5 (18.5)
Mechanical ventilation (n, %) 31 (46.3) 16 (40) 15 (55.6) 0.21
Vasopressor use (n, %) 31 (46.3) 13 (32.5) 18 (66.7) <0.01
Hemodynamic variables
CVP (mmHg) 8 (6,13) 8 (6,13.5) 9 (6,12) 0.75
CI (ml/m2) 3.5 ± 1.2 3.6 ± 1.1 3.3 ± 1.4 0.30
SBP(mmHg) 130 ± 26 127 ± 24 135 ± 28 0.20
DBP(mmHg) 66 ± 15 66 ± 16 65 ± 14 0.93
HR (/min) 101 ± 21 104 ± 20 97 ± 23 0.23
SI (ml/m2) 35 ± 12 35 ± 11 34 ± 14 0.76
SVRI 1967 (1518,2573) 1850 (1466,2347) 2103 (1566,2917) 0.09
EVLWI 11.0 ± 7.3 10.5 ± 6.6 11.8 ± 8.2 0.45
GEDVI 746 (616,833) 744 (613,877) 751 (619,818) 0.55
Fluid balance (ml)
Day 1 1432 (867,2133) 1003 (553,1827) 1890 (1432,2398) <0.01
Day 2 988 (210,1322) 499 (142,1003) 1234 (994,1332) <0.01
Day 3 324 (−324, 921) 391 (−183,1002) 122 (−1044,589) 0.16
Total 2444 (1132,3652) 2051 (874,3201) 3086 (1643,4511) 0.03
BNP0 (pg/ml) 668 (457,818) 550 (331,768) 738 (596,937) <0.01
BNP1 (pg/ml) 689 (534,889) 594 (446,732) 834 (701,1154) <0.01
BNP0 represents the B-type natriuretic peptide measured on ICU entry; BNP1 represents the BNP measured on day 3;
Abbreviations: APACHEII,Acute Physiology and Chronic Health Evaluation; CVP, central venous pressure; CI, cardiac index; SBP, systolic blood pressure; DBP, diastolic
blood pressure; HR, heart rate; SI, stroke volume; SVRI, systemic vascular resistance index; EVLWI, extravascular lung water; GEDVI, global end diastolic volume
index; BNP, B-type natriuretic peptide.
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709 pg/ml, the sensitivity and specificity were 60.6% and
70.6%, respectively. ΔBNP had no value in discrimina-
ting survivors and non-survivors. However, ΔBNP was
good at predicting other clinical outcomes. The AU-ROCTable 2 Multivariate Logistic regression analysis of variables
Variables Odds rati




Day 2 fluid balance (with each 100 ml increase) 1.50
Extravascular lung water 0.83
BNP0 represents the B-type natriuretic peptide measured on ICU entry.
Abbreviations: APACHEII, Acute Physiology and Chronic Health Evaluation; CVP, centof ΔBNP in predicting duration of MV > 7 days was 0.80,
and at the cutoff of 108 pg/ml, the sensitivity and specifi-
city were 52.9% and 85.7%, respectively. The AU-ROC of
ΔBNP in predicting LOSICU > 7 days was 0.84, and at the
cutoff of 101 pg/ml, the sensitivity and specificity wereassociated with mortality








Table 3 Diagnostic performance of BNP0 and ΔBNP on clinical outcomes
Outcomes AU-ROC Cutoff (pg/ml) Sensitivity Specificity LR+ LR−
BNP0
Mortality 0.71 (0.59-0.84) >816 48.2 87.5 3.85 0.59
Duration of MV > 7 days 0.79 (0.62-0.85) >929 57.1 88.2 4.86 0.49
LOS in ICU > 7 days 0.66 (0.53-0.79) >828 40 89.2 3.70 0.67
LOS in hospital > 12 days 0.71 (0.58-0.83) >709 60.6 70.6 2.06 0.56
ΔBNP
Mortality 0.58 (0.44-0.72) >294 40.7 77.5 1.81 0.76
Duration of MV > 7 days 0.80 (0.60-0.99) >108 52.9 85.7 3.71 0.55
LOS in ICU > 7 days 0.84 (0.74-0.93) >101 73.0 80.0 3.65 0.34
LOS in hospital > 12 days 0.85 (0.75-0.94) >114 73.5 87.9 6.07 0.30
BNP0 represents the B-type natriuretic peptide measured on ICU entry; ΔBNP represents the difference between BNP measured on the third day and BNP0 (BNP1-BNP0);
Abbreviation: LOS, length of stay; MV, mechanical ventilation.
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dicting LOShospital >12 days was 0.85, and at the cutoff of
114 pg/ml, the sensitivity and specificity were 73.5% and
87.9%, respectively.Correlation between ΔBNP and fluid balance
As shown in Figure 2, ΔBNP was significantly correla-
ted to the fluid balance with a Spearman’s rho of 0.63
(p < 0.01). Multivariate linear regression was performed
by incorporating variables that might have potential im-
pact on BNP concentrations. These variables included
age, sex, baseline BNP (BNP0), CVP, CI, and vasopressor
use. The result showed that fluid balance was independ-
ently associated with ΔBNP after adjustment (coefficient:
0.1, 95% CI: 0.07-0.13; p < 0.01). With each 100 ml in-
crease in fluid balance, the BNP increased by 10 pg/ml.Figure 2 The correlation between fluid balance and changes in
B-type natriuretic peptide (ΔBNP). ΔBNP was significantly
correlated to the amount of fluid balance over the first three days
(Spearman’s rho = 0.63, p < 0.01).Discussion
The study showed that elevated baseline BNP was asso-
ciated with significantly increased risk of mortality, lo-
nger LOSICU and LOShospital, and longer duration of MV
in patients with sepsis. Furthermore, ΔBNP was also as-
sociated with poor clinical outcomes including longer
duration of MV, LOSICU and LOShospital. Of note, the
AU-ROC of ΔBNP in predicting LOSICU and LOShospital
were 0.84 and 0.85, respectively, allowing for accurate
prediction of these outcomes by serial measurements of
BNP. However, its diagnostic value in predicting dur-
ation of MV is suboptimal with a sensitivity and specifi-
city of 52.9% and 85.7%, respectively. With correlation
analysis, we found that ΔBNP was independently asso-
ciated with the amount of net fluid balance, indicating
that copious fluid loading during resuscitation period
may impair cardiac function, and consequently resulting
in poor clinical outcomes.
The association of elevated baseline BNP with increased
risk of mortality has been proven in multiple studies
[18,19]. This association may be attributable to sepsis-
related cardiac depression that is characterized by myocar-
dial stiffness and mechanical insufficiency. In response to
myocardial stretch, the plasma BNP level will increase. In
the present study, survivors tended to have higher cardiac
index at a lower GEDVI than non-survivors, suggesting
that the depressed myocardium in non-survivors required
higher preload to compensate for compromised cardiac
output. Our result is in line with a recent study demon-
strating that elevated BNP was associated poor cardiac
prognosis, and this was mediated by cardiac rebound
stretch [20]. However, our result is limited by that echo-
cardiography, which could provide more data on cardiac
performance, was not obtained. This is because our
department is not equipped with echocardiography. The
best cutoff values used to discriminate survivors and non-
survivors varied across studies, ranging from 49 to
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standardization [21]. Although the currently existing BNP
assays correlate closely, the lack of standardization will
prohibit the communication among studies from different
institutions. In our study, the cutoff value was 810 pg/ml,
which was higher than that reported in the literature. This
was probably due to the fact that these studies were con-
ducted in emergency department, and the severity of ill-
ness of the study population was less than that in our
study. Several studies failed to demonstrate the association
of BNP with outcomes. Sturgess DJ et al. [22] showed that
BNP levels were not significantly different between survi-
vors and non-survivors (p = 0.14). However, this study en-
rolled only 21 subjects, lacking the statistical power to
detect a difference. Furthermore, the renal function, a well
known factor responsible for plasma BNP level, was not
taken into consideration in their study. The sensitivity of
BNP in predicting outcomes is low, that is, normal BNP
will not guarantee a good clinical outcome in critically ill
patients. This supports the notion that there is no single
biomarker that can be used for clinical decision making in
critically ill patients and comprehensive clinical assess-
ment is indispensible.
The identification of baseline BNP as a predictor of
outcome is not the end of investigation. The next ques-
tion would focus on whether the changes in BNP during
ICU stay could influence the outcome, and whether
modifiable factors that are responsible for the change
in BNP could be identified. The present study showed
that ΔBNP performed well in predicting LOSICU and
LOShospital, as well as the duration of MV. To the best of
our knowledge, our study is the first to describe this as-
sociation. Furthermore, we investigated factors that would
influence the changes in BNP. In multivariate regression
model, we found that the amount of fluid balance was in-
dependently associated with ΔBNP. This suggests that
fluid overloading is responsible for the increase in BNP
during treatment, and copious fluid infusion appears to
have negative impact on clinical outcome. BNP can be
used as an indicator to tell whether fluid loading is too
much. If BNP increases by more than 100 pg/ml during
resuscitation, fluid should be withheld and conservative
strategy could be performed. When patients are hemody-
namically stable, negative fluid balance may be beneficial.
Actually, the negative impact of fluid overloading in cri-
tically ill patients is not new. In a landmark study,
Wiedemann HP and coworkers demonstrated the adverse
effect of fluid overloading in patients with ARDS, and
recommended the conservative fluid strategy in this group
of patients [23]. Similar results have been replicated in an-
other study [24]. In septic patients, although the early goal
directed therapy (EGDT) requires copious fluid infusion
during the initial six hours, a growing body of evidence
favors the conservative strategy of fluid management[25-27]. However, although it seems clear that less fluid is
better, the quantification of the conservative strategy re-
mains to be addressed. In our study, we showed that an
increase in BNP > 100 pg/ml could predict extended LOS
in ICU and hospital, and the longer duration of MV. The
increase in BNP was significantly correlated to net fluid
balance. However, the correlation coefficient is low, indi-
cating that there are many other factors that are respon-
sible for plasma BNP concentration. These well known
factors responsible for BNP concentration include sex,
renal function, age, and tachycardia [28,29]. From a clin-
ical perspective, BNP alone cannot replace hemodynamic
monitoring for fluid resuscitation.
There are several limitations in our study. First, the
study is observational in nature and the conclusions can
only be served as hypothesis-generating, and this study
could be considered a pilot study. Further randomized
controlled trials can be performed by using BNP-direc-
ted fluid management protocol. Fluid infusion in the ex-
perimental arm will target an increase in BNP level of
less than 100 pg/ml. However, before such trials can be
started, other confounding factors of plasma BNP should
be properly defined. Second, patients with significant re-
nal dysfunction were excluded from the current analysis,
and thus the results cannot be applied to patient with
renal impairment. Because a substantial number of pa-
tients with severe sepsis present renal dysfunction, fur-
ther investigations focusing on this group of patients are
mandatory. Third, the study took place from ICU entry
to the next three days, and it is not within the most ef-
fective “early window” of resuscitation period. Further
studies conducted in the emergency department may
overcome such shortcomings. Forth, this study was con-
ducted in a single center, whether the conclusions can be
generalized to other institutions requires further multi-
center studies.
In aggregate, the study confirmed previous findings
that elevated baseline BNP was predictive of poor cli-
nical outcomes, and a ΔBNP > 100 pg/ml was predictive
of LOSICU >7 d and LOShospital > 12 d. What’s new and
provocative in our study is that ΔBNP is significantly
correlated to the amount of fluid balance. However, be-
cause the correlation coefficient is low and there are
many other factors that are responsible for BNP concen-
tration, BNP alone cannot be used for the monitoring of
fluid resuscitation.
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